In 2012, the needleless connector (NLC) market was the fastest growing segment in the infusion therapy market, increasing over the previous year. This market is expected to experience considerable growth due to continuing legislation that requires clinicians to use needleless devices and more expensive antimicrobial NLCs whenever possible. These more expensive antimicrobial NLCs are slowly increasing their penetration in the U.S. market.
The infusion pump market was the second fastest growing market, which also increased over 2011. The intravenous (IV) set market was declining in value in 2012 due to decreases in the average selling prices for primary IV sets. Primary IV sets made up the majority of the IV set market in terms of unit sales in the U.S. in 2012. The infusion pump market is expected to grow over the forecast period due to the increasing patient population for infusion therapy.